Baxter International Inc. (BAX) - Product Pipeline Analysis

GlobalData
November 28, 2012
43 Pages - SKU: GBDT4925588


Summary

Baxter International Inc. (Baxter) is a globally diversified healthcare company. It undertakes the development, manufacture and marketing of medical products, which save and sustain the lives of people. The company's products assist healthcare professionals and their patients in the treatment of complex medical conditions such as hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It conducts operations in North America, Latin America, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, the US.

The company seeks to maintain a leading position in the global healthcare market through acquisitions, partnerships and strategic alliances. In line with this strategy, Baxter acquired Synovis Life Technologies, Inc., Baxa Corporation, and Prism Pharmaceuticals, Inc., and entered into strategic agreement with Momenta Pharmaceuticals, Inc. to develop and commercialize follow-on biologic products.

This report is a source for data, analysis and actionable intelligence on the Baxter International Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.



More Medical Devices Company reports by GlobalData

Innocoll Technologies Ltd - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryInnocoll Technologies Ltd (Innocoll Technologies) is a biopharmaceutical company. The company develops and markets pharmaceutical products and medical devices for the pharmaceutical and medical markets. ...
Covidien plc (COV) - Financial and Strategic SWOT Analysis Review by GlobalData
Covidien plc (COV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile ...
Spine Smith, LP - Product Pipeline Analysis, 2014 Update by GlobalData
SummarySpine Smith, LP (SpineSmith) is a medical equipment company. The company designs and produces medical devices for stabilization and treatment. Its products include hardware technologies, ...
MicroPort Scientific Corporation (853) - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryMicroPort Scientific Corporation (MicroPort) is a medical device manufacturer. The company develops, manufactures and markets products to treat vascular diseases and disorders. Its products include ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 750  
    Site License  USD 1,500  
    Global Site License  USD 2,250  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!